Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Author:
Publisher
Proceedings of the National Academy of Sciences
Subject
Multidisciplinary
Reference44 articles.
1. Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
2. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
3. Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer
4. Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
5. Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural agents' role in cancer chemo-resistance prevention and treatment: molecular mechanisms and therapeutic prospects;PHARM PRACT-GRANADA;2024
2. Role of forkhead box proteins in regulation of doxorubicin and paclitaxel responses in tumor cells: A comprehensive review;International Journal of Biological Macromolecules;2023-09
3. Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo;Journal of Experimental & Clinical Cancer Research;2023-05-20
4. Molecular mechanisms of tumor drug resistance;Molekulyarnaya Meditsina (Molecular medicine);2023-02-02
5. Detection of circular RNAs and their potential as biomarkers predictive of drug response;2023-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3